The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stonehouse Jon P since 2015.
This trader's CIK number is 1385496.
At the time of last reporting, Stonehouse Jon P was the Director of Biocryst Pharmaceuticals Inc. (stock ticker symbol BCRX).
Also see all insider trading activities at Biocryst Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | BLCM | 0 | $0 | 0 | $0 | 121,452 | $0 |
| 2022 | BLCM | 0 | $0 | 0 | $0 | 82,084 | $0 |
| 2018 | BLCM | 10,000 | $45,599 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | BCRX | 0 | $0 | 0 | $0 | 305,995 | $985,303 |
| 2024 | BCRX | 30,000 | $166,500 | 0 | $0 | 0 | $0 |
| 2023 | BCRX | 0 | $0 | 100,000 | $1,038,000 | 131,055 | $644,997 |
| 2022 | BCRX | 0 | $0 | 1,076,719 | $14,323,111 | 1,076,719 | $2,137,979 |
| 2020 | BCRX | 0 | $0 | 134,278 | $1,117,192 | 134,278 | $557,253 |
| 2019 | BCRX | 50,000 | $72,500 | 0 | $0 | 0 | $0 |
| 2018 | BCRX | 0 | $0 | 80,000 | $729,599 | 207,376 | $381,659 |
| 2016 | BCRX | 0 | $0 | 0 | $0 | 24,096 | $99,998 |
| 2015 | BCRX | 0 | $0 | 20,000 | $300,400 | 53,868 | $423,981 |
1. Bellicum Pharmaceuticals, Inc (BLCM)
2. Biocryst Pharmaceuticals Inc (BCRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-03 | BLCM | Option Ex | 121,452 | .00 | 0 |
| 2022-09-01 | BLCM | Option Ex | 60,580 | .00 | 0 |
| 2022-01-04 | BLCM | Option Ex | 21,504 | .00 | 0 |
| 2018-11-09 | BLCM | Buy | 10,000 | 4.56 | 45,599 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-02 | BCRX | Option Ex | 305,995 | 3.22 | 985,303 |
| 2024-05-13 | BCRX | Buy | 30,000 | 5.55 | 166,500 |
| 2023-03-21 | BCRX | Option Ex | 31,055 | 3.22 | 99,997 |
| 2023-02-01 | BCRX | Option Ex | 100,000 | 5.45 | 545,000 |
| 2023-02-01 | BCRX | Sale | 100,000 | 10.38 | 1,038,000 |
| 2022-12-01 | BCRX | Sale | 214,917 | 13.00 | 2,793,921 |
| 2022-12-02 | BCRX | Option Ex | 82,656 | 1.42 | 117,371 |
| 2022-12-01 | BCRX | Option Ex | 214,917 | 1.42 | 305,182 |
| 2022-12-02 | BCRX | Sale | 82,656 | 12.80 | 1,057,996 |
| 2022-12-01 | BCRX | Sale | 214,917 | 13.00 | 2,793,921 |
| 2022-12-02 | BCRX | Option Ex | 82,656 | 1.42 | 117,371 |
| 2022-12-01 | BCRX | Option Ex | 214,917 | 1.42 | 305,182 |
| 2022-12-02 | BCRX | Sale | 82,656 | 12.80 | 1,057,996 |
| 2022-12-01 | BCRX | Sale | 214,917 | 13.00 | 2,793,921 |
| 2022-12-02 | BCRX | Option Ex | 82,656 | 1.42 | 117,371 |
| 2022-12-02 | BCRX | Sale | 82,656 | 12.80 | 1,057,996 |
| 2022-12-01 | BCRX | Option Ex | 214,917 | 1.42 | 305,182 |
| 2022-01-11 | BCRX | Option Ex | 184,000 | 4.73 | 870,320 |
| 2022-01-11 | BCRX | Sale | 184,000 | 15.04 | 2,767,360 |
| 2020-12-15 | BCRX | Option Ex | 134,278 | 4.15 | 557,253 |
| 2020-12-15 | BCRX | Sale | 134,278 | 8.32 | 1,117,192 |
| 2019-11-18 | BCRX | Buy | 50,000 | 1.45 | 72,500 |
| 2018-12-03 | BCRX | Sale | 80,000 | 9.12 | 729,599 |
| 2018-12-03 | BCRX | Option Ex | 80,000 | 1.20 | 96,000 |
| 2018-05-17 | BCRX | Option Ex | 70,427 | 1.42 | 100,006 |
| 2018-02-28 | BCRX | Option Ex | 56,949 | 3.26 | 185,653 |
| 2016-01-20 | BCRX | Option Ex | 24,096 | 4.15 | 99,998 |
| 2015-07-15 | BCRX | Option Ex | 33,868 | 11.81 | 399,981 |
| 2015-06-19 | BCRX | Option Ex | 20,000 | 1.20 | 24,000 |
| 2015-06-19 | BCRX | Sale | 20,000 | 15.02 | 300,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stonehouse Jon P (Director of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.